Dalfaz - Medicines used in the treatment of prostatic hyperplasia.
Pharmacological action Dalfaz
Dalfaz used in cases where prostate hyperplasia benign nature provokes a disturbance of urination: means promotes urine flow by relaxing the muscle tissue of the prostate gland.
It is noticed that Dalfaz reduces the tone of the urethra, facilitates the process of emptying the bladder.
Active substance means - alfuzosin.
Dalfaz release tablets.
Dalfaz instructions for use as drug therapy in symptomatic benign prostatic hyperplasia. Also, it is used when in acute urinary retention caused by hyperplasia, requires the introduction of a catheter.
Instructions Dalfaz: how to use
Dalfaz taken after a meal inside. Chewable tablets should not be - because of the improper release of the active ingredient increases the risk of side effects of the drug.
To reduce the severity of symptoms of benign prostatic hyperplasia take one tablet Dalfaz (10mg), one p / day.
If necessary, the catheter to the patient to take prescribed 10 mg / day for 3-4 days, starting from the first day of the procedure. Thus, the patient takes the drug for 2-3 days until the catheter is installed and another day already after catheterization is completed.
Side effects Dalfaz
During treatment, patients may note Dalfaz dry mouth, headache, drowsiness, epigastric pain, dizziness, weakness. Also can begin diarrhea, fatigue, tachycardia, may appear rash, itching and swelling of the skin, reduce the pressure, skin blush.
There is evidence that due to the reception Dalfaza patient fainted, he has a brief loss of consciousness due to the deterioration of the cerebral circulation.
Failure to follow the purpose Dalfaz possible drug overdose. Its main symptom - lowering blood pressure. The patient in this case it is necessary to lie, he administered drugs that cause vasoconstriction, taking measures to increase the circulating blood volume.
Dialysis is considered an overdose alfuzosin ineffective.
Patients who take drugs to lower pressure for a few hours after taking Dalfaz may experience dizziness, fatigue, sweating, so they should be warned about this, if necessary, lay for a while and observe their condition. These symptoms often develop only at the beginning of treatment and after discontinuation of the drug are not required.
Do not take Dalfaz patients with severe liver disease, kidney disease, low pressure (orthostatic hypotension), intestinal obstruction, hypersensitivity.
Patients with coronary insufficiency Dalfaz appoint as an independent agent, only in combination with the drugs prescribed for the treatment of disease. According to the instructions Dalfaz canceled if angina does not go away or the patient's condition deteriorates.
Do not combine with Dalfaz urapidilom, prazosin, minoxidil, since It increases the likelihood of developing postural hypotension.
With careful preparation combine with the pressure reduction means. The combination of the drug with ritonavir, ketoconazole, itraconazole may lead to increased concentrations of alfuzosin in the blood.
At the beginning of therapy with Dalfaz frequently reported dizziness, blurred vision, fatigue. This warn patients whose professional activity is associated complex control mechanisms, and those who drives a car.